Seaport Therapeutics (NASDAQ:SPTX – Get Free Report) is one of 906 publicly-traded companies in the “Pharmaceuticals” industry, but how does it compare to its rivals? We will compare Seaport Therapeutics to similar businesses based on the strength of its dividends, institutional ownership, analyst recommendations, valuation, risk, earnings and profitability.
Profitability
This table compares Seaport Therapeutics and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Seaport Therapeutics | N/A | N/A | N/A |
| Seaport Therapeutics Competitors | -2,303.77% | -221.69% | -17.78% |
Valuation & Earnings
This table compares Seaport Therapeutics and its rivals gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Seaport Therapeutics | N/A | -$74.88 million | -1.98 |
| Seaport Therapeutics Competitors | $15.96 billion | $3.11 billion | 549.82 |
Analyst Recommendations
This is a summary of current recommendations and price targets for Seaport Therapeutics and its rivals, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Seaport Therapeutics | 2 | 3 | 6 | 0 | 2.36 |
| Seaport Therapeutics Competitors | 7717 | 13660 | 25545 | 994 | 2.41 |
Seaport Therapeutics presently has a consensus target price of $37.33, indicating a potential upside of 55.30%. As a group, “Pharmaceuticals” companies have a potential upside of 30.35%. Given Seaport Therapeutics’ higher possible upside, research analysts plainly believe Seaport Therapeutics is more favorable than its rivals.
Institutional & Insider Ownership
32.7% of shares of all “Pharmaceuticals” companies are held by institutional investors. 14.0% of shares of all “Pharmaceuticals” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
Seaport Therapeutics rivals beat Seaport Therapeutics on 7 of the 12 factors compared.
Seaport Therapeutics Company Profile
Seaport Therapeutics Inc. is a clinical-stage therapeutics company focused on inventing and developing new medicines for patients with depression, anxiety and other debilitating neuropsychiatric disorders. Seaport Therapeutics Inc. is based in BOSTON.
Receive News & Ratings for Seaport Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Seaport Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
